Senti Biosciences Holdings, Inc. (SNTI) stock
SNTINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.09−0.01 (-10.31%)
Close on Nov 18, 2026Market cap $2.71MP/E –Yield –
Senti Biosciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Senti Biosciences's price to sales ratio was 29.4× on Oct 31, 2024, against 3.1× a year earlier. Over the last 3 years it ranged from 1.5× to 35.8×, with a median of 10.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Oct 31, 2024 | 29.4× | +18.2 |
| 2023 | Dec 29, 2023 | 11.2× | −1.1 |
| 2022 | Dec 30, 2022 | 12.3× | – |
See a number that looks wrong?